Practice Parameter: Diagnostic assessment of the child with cerebral palsy
Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
S. Ashwal, MD,
B. S. Russman, MD,
P. A. Blasco, MD,
G. Miller, MD,
A. Sandler, MD,
M. Shevell, MD, CM, FRCP and
R. Stevenson, MD
From the Division of Child Neurology (Dr. Ashwal), Department of Pediatrics, Loma Linda University School of Medicine, CA; Departments of Pediatrics and Neurology (Dr. Russman) and Division of Neurodevelopmental Disabilities, Department of Pediatrics (Dr. Blasco), Oregon Health and Science University and Shriners Hospital for Children, Portland; Pediatrics and Neurology (Dr. Miller), Baylor College of Medicine, Houston, TX; University of North Carolina, Chapel Hill, and Olson Huff Center for Child Development (Dr. Sandler), Mission Childrens Health Services, Asheville, NC; Departments of Neurology/Neurosurgery and Pediatrics (Dr. Shevell), Department of Human Genetics, McGill University, and Division of Pediatric Neurology, Montreal Childrens Hospital, Montreal, Quebec, Canada; and Pediatrics (Dr. Stevenson), University of Virginia School of Medicine, Charlottesville.

View larger version (91K):
[in a new window]
|
Figure. Algorithm for the evaluation of the child with cerebral palsy (CP). Screening for associated conditions (mental retardation, vision/hearing impairments, speech and language delays, oral motor dysfunction, and epilepsy) is recommended. Neuroimaging (MRI preferred to CT) is recommended for further evaluation if the etiology of the childs CP has not been previously determined. In some children, additional metabolic or genetic testing may be indicated.
|
|
Copyright © 2004 by AAN Enterprises, Inc.